The Institute of Translational Medicine aims to develop therapeutic drugs based on many cutting-edge basic medical scientific research results to treat human diseases. The main task is to create new drugs with independent intellectual property rights to accelerate the transformation of basic medical research to clinical application.

The main research interests are cardiovascular drugs, cancer drugs, anti-inflammatory drugs, and metabolism disorder drugs. For example, in the development of drugs for the treatment of cardiovascular diseases, we are trying to develop therapeutic miRNA medicines with significant effects and small side effects.

Director: Dr. Lei zhang;

Tel.: 0532-82991791;

Email: dwang2100@163.com